MBX Biosciences, Inc. (MBX) Live Share Price, Invest From India

MBX Biosciences, Inc. Stock Performance

as on October 3, 2026 at 2:16 pm IST

Day's Low
Day's High
$57.95
Day's Price Range
$60.91
$58.51
0.96%
Downside
4.10%
Upside
52 Week's Low
52 Week's High
$12.94
52-Week Price Range
$72.64
$58.51
77.88%
Downside
24.15%
Upside

MBX Biosciences, Inc. share price movements today

Previous Close: $56.55
Open: $58.14
Volume: 472.7K
Market Cap: $2.7B
Day's Low - High: $57.95 - $60.91
52 Week Low - High: $12.94 - $72.64

MBX Biosciences, Inc. Historical Returns

1 Month Return: -4.74 %
3 Month Return: + 1.23 %
1 Year Return: + 250.57 %
3 Year Return: 0 %
5 Year Return: 0 %

MBX Biosciences, Inc. Stock Fundamentals & Key Indicators

Check MBX Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-2.4

Dividend Yield

0.00%

PE Ratio (TTM)

-23.62

Industry PE ratio

-12.07

PEG Ratio

4.05

Return On Equity TTM

-26.01%

MBX Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MBX Biosciences, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
MBX Biosciences, Inc.	StrongBuy	$2.7B	NA	-23.62	0.00%	0.00%
Revolution Medicines	StrongBuy	$44.1B	609.62%	-23.34	0.00%	0.00%
Moderna	Neutral	$75.4B	-44.29%	-24.08	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.5B	180.98%	30.19	86.04%	0.00%
Regeneron	Buy	$78.1B	28.80%	17.67	84.86%	0.50%

Stock Returns calculator for MBX Biosciences, Inc. Stock including INR - Dollar returns

The MBX Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MBX Biosciences, Inc. investment value today

Current value as on today

₹3,80,457

Returns

₹2,80,457

(+280.46%)

Returns from MBX Biosciences, Inc. Stock

₹2,50,569 (+250.57%)

Dollar Impact

₹29,887 (+29.89%)

Analyst Recommendation on MBX Biosciences, Inc. Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for MBX Biosciences, Inc.. Average target price of $103.4

Indian Investors' Interest in MBX Biosciences, Inc. Stock

Search interest for MBX Biosciences, Inc. Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 4, 2026 to October 4, 2026

Change:-50% versus previous 30 day period

MBX Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	0	0	0	-
Operating Income	-13	-16	-19	-18	-26	-21	-23	-25	-27	-40
EBITDA	-12	-15	-18	-15	-23	-19	-21	-22	-23	-40
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

MBX Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	0
Operating Income	-25	-35	-68	-98
EBITDA	-25	-32	-61	-86
Interest Expense	0	-	-	-
Depreciation	0	0	0	0
Income Before Tax	-26	-32	-61	-86
Income Tax Expense	-	-	-	-
Net Income	-26	-32	-61	-86
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

MBX Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Operating Cash Flow	-10	-13	-14	-16	-22	-17	-21	-18	-20	-22
Investing Cash Flow	15	-7	-100	-67	3	25	17	-129	-97	29
Financing Cash Flow	0	-1	235	0	0	1	187	0	87	2
Change in Cash	4	-22	120	-83	-19	9	183	-147	-29	8

MBX Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-26	-32	-61	-86
Operating Cash Flow	-23	-31	-54	-79
Investing Cash Flow	-11	-30	-160	-83
Financing Cash Flow	46	69	234	189
Change in Cash	11	6	18	25

Global Institutional Holdings in MBX Biosciences, Inc.

Check out the Institutions with significant holdings in MBX Biosciences, Inc..

Funds	Holdings
Vanguard	3.69%
iShares	3.60%
VANGUARD INDEX FUNDS	2.99%
Richard Driehaus	2.19%
Michael Rockefeller	1.87%

See all

Insights on MBX Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MBX stock has moved up by 9.1%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 316.3%

About MBX Biosciences, Inc.

MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering from chronic hypoparathyroidism. The company is also progressing with MBX 1416, a prolonged-action glucagon-like peptide-1 (GLP-1) receptor antagonist, which is undergoing Phase 1 clinical assessment. The aim of this therapy is to address post-bariatric hypoglycemia, a persistent complication often seen after weight-loss surgery. Furthermore, MBX Biosciences is developing MBX 4291, a key candidate for obesity treatment. This highly potent and long-acting prodrug functions as a co-agonist for both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is currently in investigational new drug (IND)-enabling studies, with the intention of treating obesity and its associated health issues. Founded in 2018, the company's operations are headquartered in Carmel, Indiana.

Organisation	MBX Biosciences, Inc.
Headquarters	11711 N. Meridian Street, Carmel, IN, 46032, US
Industry	Biotechnology
CEO	Steve Hoerter

Key Management of MBX Biosciences, Inc.

Name	Title
Mr. Steven L. Hoerter	Executive Chairperson, CEO & President
Mr. John W. Smither CPA	Chief Financial Officer
Dr. Andreas Moraitis M.D.	Senior Vice President of Clinical Development
Mr. Mark R. Soued M.B.A.	Chief Commercial Officer
Ms. Karen Basbaum M.B.A.	Chief Business Officer
Dr. Salomon Azoulay M.D.	Chief Medical Officer
Mr. Pete De Spain	Senior Vice President of Investor Relations & Corporate Communications
Ms. Michelle Graham	Chief Human Resources Officer
Dr. Michael A. Dorato DABT, Ph.D.	Sr. Vice President of Discovery & Non-Clinical Development
Dr. Chatan Charan Ph.D.	Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls

FAQs

What is MBX Biosciences, Inc. share price today?

MBX Biosciences, Inc. share price today is $58.51 as on October 3, 2026 at 8:46 am IST at the close of the market. MBX Biosciences, Inc. share today touched a day high of $60.91 and a low of $57.95.

What is the 52 week high and 52 week low for MBX Biosciences, Inc. share?

MBX Biosciences, Inc. share touched a 52 week high of $72.64 on August 5, 2026 and a 52 week low of $12.94 on October 17, 2025. MBX Biosciences, Inc. stock price today i.e. October 3, 2026 at 8:46 am IST is closed at $58.51,which is 19.45% down from its 52 week high and 352.16% up from its 52 week low.

What is MBX Biosciences, Inc.'s market capitalisation today?

MBX Biosciences, Inc. market capitalisation is $0.00T as on October 3, 2026 at 8:46 am IST.

How to invest in MBX Biosciences, Inc. Stock (MBX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MBX Biosciences, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy MBX Biosciences, Inc. Stock (MBX) from India?

Indian investors can start investing in MBX Biosciences, Inc. (MBX) shares with as little as ₹96.300003051758 or $1 (as of October 4, 2026 at 10:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in MBX Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on October 4, 2026 at 10:41 am IST). Based on MBX Biosciences, Inc. share’s latest price of $58.51 as on October 3, 2026 at 8:46 am IST, you will get 0.1709 shares of MBX Biosciences, Inc.. Learn more about fractional shares .